Literature DB >> 32027840

Replicational Dilution of H3K27me3 in Mammalian Cells and the Role of Poised Promoters.

Unmesh Jadhav1, Elisa Manieri1, Kodandaramireddy Nalapareddy1, Shariq Madha2, Shaon Chakrabarti3, Kai Wucherpfennig4, Megan Barefoot5, Ramesh A Shivdasani6.   

Abstract

Polycomb repressive complex 2 (PRC2) places H3K27me3 at developmental genes and is causally implicated in keeping bivalent genes silent. It is unclear if that silence requires minimum H3K27me3 levels and how the mark transmits faithfully across mammalian somatic cell generations. Mouse intestinal cells lacking EZH2 methyltransferase reduce H3K27me3 proportionately at all PRC2 target sites, but ∼40% uniform residual levels keep target genes inactive. These genes, derepressed in PRC2-null villus cells, remain silent in intestinal stem cells (ISCs). Quantitative chromatin immunoprecipitation and computational modeling indicate that because unmodified histones dilute H3K27me3 by 50% each time DNA replicates, PRC2-deficient ISCs initially retain sufficient H3K27me3 to avoid gene derepression. EZH2 mutant human lymphoma cells also require multiple divisions before H3K27me3 dilution relieves gene silencing. In both cell types, promoters with high basal H3K4me2/3 activate in spite of some residual H3K27me3, compared to less-poised promoters. These findings have implications for PRC2 inhibition in cancer therapy.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Ezh2; PRC2; epigenetic memory; gene repression; poised promoters

Mesh:

Substances:

Year:  2020        PMID: 32027840      PMCID: PMC7376365          DOI: 10.1016/j.molcel.2020.01.017

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  59 in total

1.  Coordinated activities of wild-type plus mutant EZH2 drive tumor-associated hypertrimethylation of lysine 27 on histone H3 (H3K27) in human B-cell lymphomas.

Authors:  Christopher J Sneeringer; Margaret Porter Scott; Kevin W Kuntz; Sarah K Knutson; Roy M Pollock; Victoria M Richon; Robert A Copeland
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-15       Impact factor: 11.205

2.  Polycomb limits the neurogenic competence of neural precursor cells to promote astrogenic fate transition.

Authors:  Yusuke Hirabayashi; Nao Suzki; Masafumi Tsuboi; Takaho A Endo; Tetsuro Toyoda; Jun Shinga; Haruhiko Koseki; Miguel Vidal; Yukiko Gotoh
Journal:  Neuron       Date:  2009-09-10       Impact factor: 17.173

3.  Causal role for inheritance of H3K27me3 in maintaining the OFF state of a Drosophila HOX gene.

Authors:  Rory T Coleman; Gary Struhl
Journal:  Science       Date:  2017-03-16       Impact factor: 47.728

4.  Ezh1 is required for hematopoietic stem cell maintenance and prevents senescence-like cell cycle arrest.

Authors:  Isabel Hidalgo; Antonio Herrera-Merchan; Jose Manuel Ligos; Laura Carramolino; Javier Nuñez; Fernando Martinez; Orlando Dominguez; Miguel Torres; Susana Gonzalez
Journal:  Cell Stem Cell       Date:  2012-11-02       Impact factor: 24.633

5.  PRC2 preserves intestinal progenitors and restricts secretory lineage commitment.

Authors:  Fulvio Chiacchiera; Alessandra Rossi; SriGanesh Jammula; Marika Zanotti; Diego Pasini
Journal:  EMBO J       Date:  2016-09-01       Impact factor: 11.598

Review 6.  Genome Regulation by Polycomb and Trithorax: 70 Years and Counting.

Authors:  Bernd Schuettengruber; Henri-Marc Bourbon; Luciano Di Croce; Giacomo Cavalli
Journal:  Cell       Date:  2017-09-21       Impact factor: 41.582

7.  EZH2 is required for germinal center formation and somatic EZH2 mutations promote lymphoid transformation.

Authors:  Wendy Béguelin; Relja Popovic; Matt Teater; Yanwen Jiang; Karen L Bunting; Monica Rosen; Hao Shen; Shao Ning Yang; Ling Wang; Teresa Ezponda; Eva Martinez-Garcia; Haikuo Zhang; Yupeng Zheng; Sharad K Verma; Michael T McCabe; Heidi M Ott; Glenn S Van Aller; Ryan G Kruger; Yan Liu; Charles F McHugh; David W Scott; Young Rock Chung; Neil Kelleher; Rita Shaknovich; Caretha L Creasy; Randy D Gascoyne; Kwok-Kin Wong; Leandro Cerchietti; Ross L Levine; Omar Abdel-Wahab; Jonathan D Licht; Olivier Elemento; Ari M Melnick
Journal:  Cancer Cell       Date:  2013-05-13       Impact factor: 31.743

8.  Ezh2 controls B cell development through histone H3 methylation and Igh rearrangement.

Authors:  I-Hsin Su; Ashwin Basavaraj; Andrew N Krutchinsky; Oliver Hobert; Axel Ullrich; Brian T Chait; Alexander Tarakhovsky
Journal:  Nat Immunol       Date:  2002-12-23       Impact factor: 25.606

9.  HTSeq--a Python framework to work with high-throughput sequencing data.

Authors:  Simon Anders; Paul Theodor Pyl; Wolfgang Huber
Journal:  Bioinformatics       Date:  2014-09-25       Impact factor: 6.937

10.  Multiple modes of PRC2 inhibition elicit global chromatin alterations in H3K27M pediatric glioma.

Authors:  James M Stafford; Chul-Hwan Lee; Philipp Voigt; Nicolas Descostes; Ricardo Saldaña-Meyer; Jia-Ray Yu; Gary Leroy; Ozgur Oksuz; Jessica R Chapman; Fernando Suarez; Aram S Modrek; N Sumru Bayin; Dimitris G Placantonakis; Matthias A Karajannis; Matija Snuderl; Beatrix Ueberheide; Danny Reinberg
Journal:  Sci Adv       Date:  2018-10-31       Impact factor: 14.136

View more
  22 in total

Review 1.  Polycomb Gene Silencing Mechanisms: PRC2 Chromatin Targeting, H3K27me3 'Readout', and Phase Separation-Based Compaction.

Authors:  Yiran Guo; Shuai Zhao; Gang Greg Wang
Journal:  Trends Genet       Date:  2021-01-22       Impact factor: 11.639

Review 2.  Role of epigenetics in cellular reprogramming; from iPSCs to disease modeling and cell therapy.

Authors:  Yong Li; Radbod Darabi
Journal:  J Cell Biochem       Date:  2021-10-19       Impact factor: 4.429

3.  Investigating Histone Modification Dynamics by Mechanistic Computational Modeling.

Authors:  Govind Menon; Martin Howard
Journal:  Methods Mol Biol       Date:  2022

Review 4.  Context-specific Polycomb mechanisms in development.

Authors:  Jongmin J Kim; Robert E Kingston
Journal:  Nat Rev Genet       Date:  2022-06-09       Impact factor: 59.581

5.  EED is required for mouse primordial germ cell differentiation in the embryonic gonad.

Authors:  Matthew G Lowe; Ming-Ren Yen; Fei-Man Hsu; Linzi Hosohama; Zhongxun Hu; Tsotne Chitiashvili; Timothy J Hunt; Isaac Gorgy; Matthew Bernard; Sissy E Wamaitha; Pao-Yang Chen; Amander T Clark
Journal:  Dev Cell       Date:  2022-06-08       Impact factor: 13.417

Review 6.  Regulation, functions and transmission of bivalent chromatin during mammalian development.

Authors:  Trisha A Macrae; Julie Fothergill-Robinson; Miguel Ramalho-Santos
Journal:  Nat Rev Mol Cell Biol       Date:  2022-08-26       Impact factor: 113.915

Review 7.  Epigenetic Regulation of Intestinal Stem Cells and Disease: A Balancing Act of DNA and Histone Methylation.

Authors:  Alireza Lorzadeh; Maile Romero-Wolf; Ajay Goel; Unmesh Jadhav
Journal:  Gastroenterology       Date:  2021-03-26       Impact factor: 33.883

8.  FBXO11-mediated proteolysis of BAHD1 relieves PRC2-dependent transcriptional repression in erythropoiesis.

Authors:  Peng Xu; Daniel C Scott; Beisi Xu; Yu Yao; Ruopeng Feng; Li Cheng; Kalin Mayberry; Yong-Dong Wang; Wenjian Bi; Lance E Palmer; Moeko T King; Hong Wang; Yuxin Li; Yiping Fan; Arno F Alpi; Chunliang Li; Junmin Peng; James Papizan; Shondra M Pruett-Miller; Ria Spallek; Florian Bassermann; Yong Cheng; Brenda A Schulman; Mitchell J Weiss
Journal:  Blood       Date:  2021-01-14       Impact factor: 25.476

9.  Age-related changes in polycomb gene regulation disrupt lineage fidelity in intestinal stem cells.

Authors:  Helen M Tauc; Imilce A Rodriguez-Fernandez; Jason A Hackney; Michal Pawlak; Tal Ronnen Oron; Jerome Korzelius; Hagar F Moussa; Subhra Chaudhuri; Zora Modrusan; Bruce A Edgar; Heinrich Jasper
Journal:  Elife       Date:  2021-03-16       Impact factor: 8.140

10.  LncRNA LINC00525 suppresses p21 expression via mRNA decay and triplex-mediated changes in chromatin structure in lung adenocarcinoma.

Authors:  Panqi Fang; Hao Chen; Zhifei Ma; Chencheng Han; Wenda Yin; Siwei Wang; Hongyu Zhu; Wenjia Xia; Jie Wang; Lin Xu; Tongyan Liu; Rong Yin
Journal:  Cancer Commun (Lond)       Date:  2021-06-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.